Covaris
Launch date
Employees
Woburn Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | $150k | Grant | |
* | $730k | Grant | |
* | N/A | Acquisition | |
Total Funding | AUD1.4m |
Recent News about Covaris
EditMore about Covaris
EditCovaris provides tools and technologies to improve pre-analytical sample preparation, enable novel drug formulations, and manage compounds in the drug discovery process. The Covaris technological foundation is based on its proprietary and patented AFA⢠technology. AFA enables a vast array of non-contact, isothermal processes to be developed for use in a broad range of applications in Genomics, Proteomics, Cell Biology and Drug Discovery, and Formulation. Thousands of Focused-ultrasonicators are in use in over 30 countries and customers include the worldâs leading researchers, universities, and pharmaceutical companies.
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.